CRYO CELL INTERNATIONAL INC

CRYO CELL INTERNATIONAL INC (CCEL) is a publicly traded US company. Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

The company reports trailing twelve-month revenue of $6.53M and net income of $47,108.

Key metrics include a return on equity of -0.3%, a debt-to-equity ratio of -4.31.

Investors tracking CCEL can follow price movements, analyst estimates, and fundamental changes directly through FINOTAUR's research tools.